Öffentliches Bankwesen

Öffentliche Nabelschnurblutbanken unterstützen die Gesundheit der Gemeinschaft. Sie sammeln Nabelschnurblutspenden von gesunden Schwangeren und lagern diese ein. Man kann mit diesem Nabelschnurblut das Leben eines Patienten retten, wenn dieser eine Stammzelltransplantation eines gesunden Spenders benötigt und eine Übereinstimmung der Gewebemerkmale zwischen Spender und Empfänger bestätigt ist. In Deutschland ist das größte Spenderregister die Deutsche Knochenmarkspenderdatei (DKMS). Patienten mit einem seltenen genetischen Gewebetyp erhalten eher Nabelschnurbluttransplantation. Falls Eltern das Nabelschnurblut ihres Neugeborenen an eine öffentliche Bank spenden möchten, muss die Entbindung in einem Krankenhaus erfolgen, welches mit der öffentlichen Nabelschnurblutbank zusammen kooperiert.


Beike Biotech

16F Beike Building, 18 Keyuan Rd., South Area, Hi-Tech Industrial Park, Nanshan, China 518057, Shenzhen

Beike Biotechnology is one of the leading Chinese companies conducting clinical studies in the field of regenerative medicine with stem cells.

Global Cord Blood Corp - Beijing

Yongchang North Road, Daxing, Beijing, CHINA

Global Cord Blood Corporation, formerly known as China Cord Blood Corporation (NYSE: CO) is the largest umbilical cord blood banking operator in China. Global Cord Blood Corporation owns the cord blood banking licenses for the provinces of Beijing, Guangdong, Zhejiang, and holds a stake in the province of Shandong.

Global Cord Blood Corp - Guangdong

1 Nanyun 4th Rd, Huangpu, Guangzhou, Guangdong, CHINA

Global Cord Blood Corporation, formerly known as China Cord Blood Corporation (NYSE: CO) is the largest umbilical cord blood banking operator in China. Global Cord Blood Corporation owns the cord blood banking licenses for the provinces of Beijing, Guangdong, Zhejiang, and holds a stake in the province of Shandong.

Global Cord Blood Corp - Zhejiang

BLDG25, 1218 Wenyi West Road, Dist Yuhang, Hangzhou, Zhejiang 311121 CHINA

Global Cord Blood Corporation, formerly known as China Cord Blood Corporation (NYSE: CO) is the largest umbilical cord blood banking operator in China. Global Cord Blood Corporation owns the cord blood banking licenses for the provinces of Beijing, Guangdong, Zhejiang, and holds a stake in the province of Shandong.

Shanghai Cord Blood Bank

1191 Hongqiao Road, Changning District, 200051 China., Shanghai

Shanghai Cord Blood Bank holds the PRC government license for cord blood banking in the Shanghai region.

SiChuan Cord Blood Bank

15 JinQuan Road, JinNiu District, Chengdu, Sichuan province, China, Chengdu

SiChuan Cord Blood Bank (SCCBB) is one of the seven banking operators approved by the National Health and Family Planning Commission (NHFPC), People's Republic of China.

Sinocord (Shandong Cord Blood Bank)

Qilu Hospital of Shandong University, Lixia, Shandong, China, 250000

China Cord Blood Corp (CCBC) owns a stake in the Shandong Province Cord Blood Bank located in Jinan High-tech Development Zone, Qilu Hospital of Shandong University, Shandong Province of China.

Tianjin Cord Blood Bank

Tianjin New Technology Industrial Park, No. 12, Meiyuan Road, Huayuan Industrial Zone, 300384 Tianjin, China, Tianjin

The Tianjin "model" of stem cell translational medicine can be traced back to the founding of a national center of excellence in hematology research and education in 1957. The Tianjin model was studied in a paper published in 2008 and again in 2020 it was published in the academic literature.